JJ PHARMA CONSULT ApS: Financial statements 2024
CVR: 33257635
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -53,638 and a net result of DKK 1,260,145 compared with DKK 17,488,303 the year before. Equity in the 2024 report amounted to DKK 19,106,217. The solvency ratio was 98%.
- Gross Profit
- DKK -53,638
- Profit/Loss
- DKK 1,260,145
- Equity
- DKK 19,106,217
- Total Assets
- DKK 19,491,520
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -54 t. | 1.3 mio. | 19.1 mio. | - |
| 2023 | - | -13 t. | 17.5 mio. | 18.8 mio. | - |
| 2022 | - | -19 t. | 480 t. | 2.4 mio. | 0 |
| 2021 | - | -14 t. | -593 t. | 2 mio. | - |
| 2020 | - | -20 t. | 1 mio. | 2.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
JJ PHARMA CONSULT ApS has published its annual report for 2023. Gross profit came to DKK -12,891, and the net result was DKK 17,488,303.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.